Search

Patients with a rare blood cancer that had relapsed or become resistant to treatment have shown a high response rate to a potent new immunotherapy drug, in a Peter Mac-led clinical trial. The early-phase NP30179 trial involved... Read more

A Peter Mac-initiated clinical trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma, who otherwise have a 50% chance of cure from conventional therapy. Patients enrolled... Read more

At the same time the pandemic placed a huge burden on hospital infection prevention teams, it triggered a rapid overhaul of the way they delivered training. Bringing people into a room for... Read more

Each year around 2,400 Australians are diagnosed with sarcoma. For one of Australia’s rarer cancers, it can have a big and lasting impact particularly on the young. “Sarcoma is a cancer that disproportionately affects young... Read more

Peter Mac’s Professor Joe Trapani AO has been named in the Australia Day Honours List and appointed an Officer of the Order of Australia (AO). Professor Trapani is cited for his ‘distinguished service to medical research,... Read more

Four Peter Mac staff have been recognised for their leadership at the 2025 VCCC Alliance Awards, that celebrate excellence and leadership in cancer research and care. The award ceremony held on 5 November, saw three Peter Mac... Read more